daily oral glp-1 receptor agonist orforglipron for adults with obesity FDA approves Lilly's Foundayo (orforglipron) pill weight loss FDA approves Foundayo, an oral
Description
Transl Oncol
[DOI] [PubMed] [Google Scholar] 22.Tsukiyama K, Yamada Y, Yamada C, et al
Klein DJ, Battelino T, Chatterjee DJ, Jacobsen LV, Hale PM, Arslanian S
At HormoneSynergy Clinic, we use medication thoughtfully when it is appropriate
Additionally, GLP-1 has been shown to enhance the proliferation and differentiation of endothelial progenitor cells through upregulation of VEGF, potentially promoting angiogenesis that could contribute to retinal complications [101,102]
